Latest News and Press Releases
Want to stay updated on the latest news?
-
CLEVELAND, July 14, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2015 financial results at approximately 4:00 PM EDT on Thursday, August 6, 2015, and host...
-
CLEVELAND, May 11, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended March 31, 2015. Highlights of the first quarter of 2015 and...
-
CLEVELAND, April 24, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will be hosting a shareholder conference call on Wednesday, April 29, 2015 to present the recently...
-
CLEVELAND, April 17, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced interim results from its exploratory Phase 2 clinical study of the intravenous administration of...
-
CLEVELAND, April 14, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2015 financial results at approximately 4:00 PM EDT on Monday, May 11, 2015, and host a...
-
CLEVELAND, April 8, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Dr. David Hess, a stroke specialist and Chairman of the Department of Neurology at the Medical College of...
-
CLEVELAND, March 19, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that it will be participating in the 12th annual BIO Asia International Conference to be held on March 24-25,...
-
CLEVELAND, March 12, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2014. "We have started off this...
-
CLEVELAND and TOKYO, March 2, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) and Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange:4519) have announced a partnership and license agreement...
-
CLEVELAND and TOKYO, March 2, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) and Chugai Pharmaceutical Co., Ltd. (Tokyo Stock Exchange: 4519) have announced a partnership and license agreement...